Allergy Immunotherapies (Allergy Immunotherapy) Industry
Description
Wiseguyreports.Com Adds “Allergy Immunotherapies (Allergy Immunotherapy) -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast to 2025” To Its Research Database
This report studies the global Allergy Immunotherapies (Allergy Immunotherapy) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Allergy Immunotherapies (Allergy Immunotherapy) market by companies, region, type and end-use industry.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system’s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
The classification of Allergy Immunotherapy includes Subcutaneous Immunotherapy and Sublingual Immunotherapy. The proportion of Subcutaneous Immunotherapy in 2017 is about 55.1%, and the proportion of Sublingual Immunotherapy in 2016 is about 44.9%.
Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.3 % in 2017.
Europe is the largest consumption place, with a consumption market share nearly 68.5% in 2017, Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction. Following Europe, North America is the second largest consumption place with the consumption market share of 19.2% in 2017. Allergy Immunotherapy market in Asia Pacific region is expected to exhibit the highest growth rate due to high incidence of allergy people in the developing Asian countries like China & India.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3308121-global-allergy-immunotherapies-allergy-immunotherapy-market-size-status
Market competition is intense. ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, etc. are the leaders of the industry with the market share is about 76.6% in 2017.
In 2017, the global Allergy Immunotherapies (Allergy Immunotherapy) market size was 1070 million US$ and it is expected to reach 2210 million US$ by the end of 2025, with a CAGR of 9.5% during 2018-2025.
This report focuses on the global top players, covered
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market segment by Application, split into
Allergic Rhinitis
Allergic Asthma
Other
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Allergy Immunotherapies (Allergy Immunotherapy) Manufacturers
Allergy Immunotherapies (Allergy Immunotherapy) Distributors/Traders/Wholesalers
Allergy Immunotherapies (Allergy Immunotherapy) Subcomponent Manufacturers
Industry Association
Downstream Vendors
Leave a Query @ https://www.wiseguyreports.com/enquiry/3308121-global-allergy-immunotherapies-allergy-immunotherapy-market-size-status
Table of Contents
Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size, Status and Forecast 2025
1 Industry Overview of Allergy Immunotherapies (Allergy Immunotherapy)
1.1 Allergy Immunotherapies (Allergy Immunotherapy) Market Overview
1.1.1 Allergy Immunotherapies (Allergy Immunotherapy) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Allergy Immunotherapies (Allergy Immunotherapy) Market by Type
1.3.1 Subcutaneous Immunotherapy
1.3.2 Sublingual Immunotherapy
1.4 Allergy Immunotherapies (Allergy Immunotherapy) Market by End Users/Application
1.4.1 Allergic Rhinitis
1.4.2 Allergic Asthma
1.4.3 Other
…
3 Company (Top Players) Profiles
3.1 ALK-Abello
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.2 Stallergenes Greer
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.3 Merck
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.4 Allergy Therapeutics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.5 HAL
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.6 WOLW Pharma
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.7 Holister Stier
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
3.8 Leti
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Allergy Immunotherapies (Allergy Immunotherapy) Revenue (Million USD) (2013-2018)
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3308121
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)